APA (7th ed.) Citation

Shretta, R., Brugha, R., Robb, A., & Snow, R. W. (2000). Sustainability, affordability, and equity of corporate drug donations: The case of Malarone. Lancet, 355(9216), 1718. https://doi.org/10.1016/S0140-6736(00)02251-0

Chicago Style (17th ed.) Citation

Shretta, R., R. Brugha, A. Robb, and R W. Snow. "Sustainability, Affordability, and Equity of Corporate Drug Donations: The Case of Malarone." Lancet 355, no. 9216 (2000): 1718. https://doi.org/10.1016/S0140-6736(00)02251-0.

MLA (9th ed.) Citation

Shretta, R., et al. "Sustainability, Affordability, and Equity of Corporate Drug Donations: The Case of Malarone." Lancet, vol. 355, no. 9216, 2000, p. 1718, https://doi.org/10.1016/S0140-6736(00)02251-0.